INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 21, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 2,877 | $571.32 | 317,932 |
| Nov 02, 2015 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Open market or private sale of non-derivative or derivative security | 7,800 | $571.41 | 561,863 |
| May 11, 2020 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 64,631 | $571.43 | 534,868 |
| May 11, 2020 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 96,947 | $571.43 | 625,421 |
| May 12, 2020 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 15,542 | $571.49 | 513,449 |
| Aug 14, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Open market or private sale of non-derivative or derivative security | 5,598 | $571.54 | 28,700 |
| Apr 20, 2020 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 114 | $571.65 | 24,757 |
| Apr 20, 2020 |
EVP General Counsel and Secret
Trans History: 181
|
EVP General Counsel and Secret | Form 4 | Open market or private sale of non-derivative or derivative security | 112 | $571.65 | 15,076 |
| May 15, 2020 |
EVP General Counsel and Secret
Trans History: 181
|
EVP General Counsel and Secret | Form 4 | Open market or private sale of non-derivative or derivative security | 8,380 | $572.00 | 14,438 |
| Apr 20, 2020 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 64 | $572.42 | 24,693 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.